Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Aegis Conference

Northwest Biotherapeutics, Inc. (NWBO) Starts Presentation at the Aegis Healthcare Conference

Northwest Biotherapeutics, Inc. is a development-stage biotechnology company engaging in the discovery, development and commercialization of immunotherapy products for treating cancers. The company’s DCVax uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The … Continue reading

Posted in Aegis Conference | Leave a comment

Amarantus BioScience Holdings, Inc. (AMBS) Starts Presentation at the Aegis Healthcare Conference

Amarantus BioScience Holdings, Inc. is a development-stage biotechnology company focusing on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases. The company is developing the Mesencephalic-Astrocyte-derived Neurotrophic Factor, a therapeutic protein for … Continue reading

Posted in Aegis Conference | Leave a comment

DS Healthcare Group, Inc. (DSKX) Starts Presentation at the Aegis Healthcare Conference

DS Healthcare Group, Inc. develops and markets hair, skin, health and personal care products. The company’s products include the Revita shampoo and Revita.Cor conditioner for hair growth stimulation; Spectral.DNC spray formula, Spectral.DNC-L lotion, and Spectral DNC-N to re-grow hair as … Continue reading

Posted in Aegis Conference | Leave a comment

Synergy Pharmaceuticals Inc. (SGYP) Starts Presentation at the Aegis Healthcare Conference

Synergy Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing drugs for treating gastrointestinal (GI) disorders and diseases. Synergy’s lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist which has completed Phase IIa clinical trials for the … Continue reading

Posted in Aegis Conference | Leave a comment

Prima BioMed Ltd. (PBMD) Starts Presentation at the Aegis Healthcare Conference

Prima BioMed Ltd. is a biotechnology company researching and developing licensed medical biotechnology products in Australia. The company’s lead product is CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. The company is also … Continue reading

Posted in Aegis Conference | Leave a comment

Stemline Therapeutics, Inc. (STML) Starts Presentation at the Aegis Healthcare Conference

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on the discovery, acquisition, development and commercialization of proprietary therapeutics that target cancer stem cells (CSCs) and tumor bulk. In addition to developing StemScreen platform technology for the identification of novel … Continue reading

Posted in Aegis Conference | Leave a comment

Rosetta Genomics Ltd. (ROSG) Starts Presentation at the Aegis Healthcare Conference

Rosetta Genomics Ltd. develops diagnostic tools for microRNAs, a group of genes produced using instructions encoded in DNA. The company offers diagnostic tests, including miRview mets2, a microRNA-based diagnostic used to identify 42 tumor types including carcinomas, soft tissue tumors, … Continue reading

Posted in Aegis Conference | Leave a comment

AtheroNova Inc. (AHRO) Starts Presentation at the Aegis Healthcare Conference

AtheroNova Inc. is a development stage company engaging in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. The company develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, the primary … Continue reading

Posted in Aegis Conference | Leave a comment

Opexa Therapeutics, Inc. (OPXA) Starts Presentation at the Aegis Healthcare Conference

Opexa Therapeutics, Inc. is a biopharmaceutical company that develops personalized cellular therapies to treat multiple sclerosis (MS) using its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for … Continue reading

Posted in Aegis Conference | Leave a comment

OHR Pharmaceutical, Inc. (OHRP) Starts Presentation at the Aegis Healthcare Conference

OHR Pharmaceutical, Inc. is a biotechnology company. The company’s products include Squalamine, an anti-angiogenic small molecule with a novel intracellular mechanism that inhibits vascular endothelial, platelet derived and basic fibroblast growth factors to treat the wet form of age-related macular … Continue reading

Posted in Aegis Conference | Leave a comment